Optimizing the Identification of HER2-Low Breast Cancer
Jul 30, 2024
23:49
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr Kimberly H Allison from the Stanford Cancer Institute in Stanford, California discusses the optimal identification, pathologic reporting and treatment of HER2-low breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
Oncology Today with Dr Neil Love